Agata Grochowska: Thromboprophylaxis and Coagulation Challenges in Pancreatic Cancer
Agata Grochowska, Ambassador and Teaching Assistant at Meta-Analysis Academy, shared on LinkedIn about a recent article she and her colleagues co-authored, adding:
”New Publication Alert | Thromboprophylaxis and Coagulation Challenges in Pancreatic Cancer
Published in Journal of Thrombosis and Thrombolysis (IF 2.2)
February 20, 2026
I’m pleased to share our latest review: ‘Coagulation disorders and thromboprophylaxis in pancreatic cancer: a review of current evidence and clinical challenges.’
Pancreatic cancer is still one of the most thrombogenic malignancies.
Venous thromboembolism (VTE) is more than just a clinical problem, playing a crucial role in survival, postoperative recovery, and the ability to deliver systemic therapy.
Highlights from our review:
- Thrombosis associated with pancreatic cancer is among the highest-risk cancers.
- Standard prophylactic dosing is widely recommended, yet largely extrapolated from non-pancreatic cancer data.
- Increased low-molecular-weight heparin (LMWH) treatment plans are effective in reducing VTE in advanced disease, but with no evidence of a survival benefit.
- Direct oral anticoagulants (DOACs) offer convenience but raise concerns regarding gastrointestinal bleeding.
- Post-pancreatectomy VTE occurs in 20-25% of patients within 90 days, with many events occurring after hospital discharge.
- Post-pancreatectomy hemorrhage (PPH) poses a fundamental therapeutic issue: when and how to safely resume anticoagulation remains insufficiently defined.
The central challenge: balancing thrombosis prevention with bleeding risk in one of the most complex oncologic surgical populations.
Our review highlights the urgent need for pancreatic cancer-specific randomized trials and clearer perioperative anticoagulation strategies.
Pancreatic cancer care is not only about resection margins and chemotherapy protocols; it is also about understanding and managing the profound hemostatic imbalance that defines this disease.
A huge thank you to the co-authors: Dr. Julia Kaczorowska, Dr. Maciej Świerczyna, Dr. Wojciech Ciesielski, Prof. Adam Durczyński, Prof. Janusz Strzelczyk, and Prof. Piotr Hogendorf from the Department of General and Transplant Surgery, Medical University of Lodz.”
Title: Coagulation disorders and thromboprophylaxis in pancreatic cancer: a review of current evidence and clinical challenges
Authors: Agata Grochowska, Julia Kaczorowska, Maciej Świerczyna, Wojciech Ciesielski, Adam Durczyński, Janusz Strzelczyk, Piotr Hogendorf
Read the Full Article on Journal of Thrombosis and Thrombolysis
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 13:51Matías J Alet: Hospital Carlos Saporiti on the Path to Essential Stroke Center Recognition
-
Apr 15, 2026, 13:39Congratulations to Sandy Middleton for Taking the 2026 HESTA Australian Nursing and Midwifery Awards – Stroke Foundation
-
Apr 15, 2026, 13:25Wolfgang Miesbach: Platelet Variation and How Do They Move Over Time?
-
Apr 15, 2026, 12:44Marwa Elnahas: 4Ts Scoring Tool for Heparin – Induced Thrombocytopenia
-
Apr 15, 2026, 12:27Laurent Bertoletti: Joining Global Experts to Improve Thrombosis Care in Cancer for the ICTHIC 16th Edition
-
Apr 15, 2026, 12:13Francesco Antonio Veneziano: JCDD MDPI Calls for Papers on Advances in Thrombosis and Antithrombotic Therapy
-
Apr 15, 2026, 11:05Julius Kyei Baffour: Understanding Thrombophilia Testing and Patient Risk
-
Apr 15, 2026, 09:10Shall I Bleed Less with Age? Just 2 Weeks Until the Webinar – EHC
-
Apr 15, 2026, 08:51Moustafa Abdou: Sutimlimab is Transforming Outcomes in Cold Agglutinin Disease